Silence Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Silence Therapeutics stock has a consensus rating of "Buy" and an average price target of $33. The average 1-year stock price forecast is 68.54% higher than the current stock price, while the lowest is $10 (-48.93%) and the highest is $75 (+283.04%).

Price Target: $33 (+68.54%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$10	$33	$29.5	$75
Change	-48.93%	+68.54%	+50.66%	+283.04%

Analyst Ratings

The average analyst rating for Silence Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	4	5	5	5	5	5
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	6	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Tsai Jefferies	Jefferies	Hold Downgrades $35 → $20	Hold	Downgrades	$35 → $20	+2.15%	Oct 19, 2026
Myles Minter William Blair	William Blair	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Oct 19, 2026
Keay Nakae Chardan Capital	Chardan Capital	Hold Downgrades $27 → $20	Hold	Downgrades	$27 → $20	+2.15%	Oct 19, 2026
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Maintains $75	Buy	Maintains	$75	+283.04%	Sep 21, 2026
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Reiterates $25 → $32	Buy	Reiterates	$25 → $32	+63.43%	Aug 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

434.29K

from 559.00K

-22.31%

from 559.00K

Revenue Next Year

1.00M

from 434.29K

130.93%

from 434.29K

EPS This Year

-0.36

EPS Next Year

-0.38

from -0.36

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	16.81M	21.66M	31.64M	43.26M	559.00K	434.29K
Revenue Growth	124.73%	28.82%	46.12%	36.71%	-98.71%	-22.31%
Operating Income	-62.03M	-51.22M	-52.43M	-49.58M	-82.29M	-59.79M
Net Income	-53.36M	-50.33M	-54.23M	-45.31M	-88.61M	-56.36M
EPS	-	-	-	-	-	-0.36
Free Cash Flow	-	-	-	-	-66.67M	-44.45M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	617,340
Avg	434,289.3
Low	395,525.2

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	10.4%
Avg	-22.3%
Low	-29.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.36
Avg	-0.36
Low	-0.36

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-